SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007138
Filing Date
2023-03-10
Accepted
2023-03-10 07:35:19
Documents
14
Period of Report
2023-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K freq-20230310.htm   iXBRL 8-K 61795
2 EX-99.1 freq-ex99_1.htm EX-99 191858
3 GRAPHIC img198726637_0.jpg GRAPHIC 4596
  Complete submission text file 0000950170-23-007138.txt   399778

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT freq-20230310_lab.xml EX-101.LAB 18515
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT freq-20230310.xsd EX-101.SCH 2471
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT freq-20230310_pre.xml EX-101.PRE 11566
8 EXTRACTED XBRL INSTANCE DOCUMENT freq-20230310_htm.xml XML 4889
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 23721608
SIC: 2834 Pharmaceutical Preparations